Funder
Medical Science and Technology Project of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Baudin P, Cousyn L, Navarro V (2021) The LGI1 protein: molecular structure, physiological functions and disruption-related seizures. Cell Mol Life Sci 79(1):16. https://doi.org/10.1007/s00018-021-04088-y
2. Teng Y, Li T, Yang Z, Su M, Ni J, Wei M, Shi J, Tian J (2022) Clinical features and therapeutic effects of anti-leucine-rich glioma inactivated 1 encephalitis: a systematic review. Front Neurol 12:791014. https://doi.org/10.3389/fneur.2021.791014
3. Ghimire P, Khanal UP, Gajurel BP, Karn R, Rajbhandari R, Paudel S, Gautam N, Ojha R (2020) Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: a systematic review. Brain Behav 10(10):e01793. https://doi.org/10.1002/brb3.1793
4. Trewin BP, Freeman I, Ramanathan S, Irani SR (2022) Immunotherapy in autoimmune encephalitis. Curr Opin Neurol 35(3):399–414. https://doi.org/10.1097/WCO.0000000000001048
5. Chinese Society of Neuroinfectious Diseases and Cerebrospinal Fluid Cytology (2022) Chinese expert consensus on the diagnosis and management of autoimmune encephalitis (2022 edition). Chin J Neurol 55(9):931–949